These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 28412920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
    Solowij N, Broyd S, Greenwood LM, van Hell H, Martelozzo D, Rueb K, Todd J, Liu Z, Galettis P, Martin J, Murray R, Jones A, Michie PT, Croft R.
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The pharmacokinetics and the pharmacodynamics of cannabinoids.
    Lucas CJ, Galettis P, Schneider J.
    Br J Clin Pharmacol; 2018 Nov; 84(11):2477-2482. PubMed ID: 30001569
    [Abstract] [Full Text] [Related]

  • 7. Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review.
    Smith SA, Le GH, Teopiz KM, Kwan ATH, Rhee TG, Ho RC, Wu J, Cao B, Ceban F, McIntyre RS.
    Drug Metab Rev; 2024 Nov; 56(2):164-174. PubMed ID: 38655747
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.
    Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M.
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.
    Greenwood LM, Broyd SJ, van Hell HH, Todd J, Jones A, Murray RM, Croft RJ, Michie PT, Solowij N.
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [Abstract] [Full Text] [Related]

  • 15. Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol.
    Alves P, Amaral C, Teixeira N, Correia-da-Silva G.
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of Medical Cannabis.
    Amin MR, Ali DW.
    Adv Exp Med Biol; 2019 Jul; 1162():151-165. PubMed ID: 31332738
    [Abstract] [Full Text] [Related]

  • 17. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N, Pietrafusa N, Cross HJ.
    Epileptic Disord; 2020 Jan 01; 22(S1):1-9. PubMed ID: 31941643
    [Abstract] [Full Text] [Related]

  • 18. Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats.
    Silveira MM, Adams WK, Morena M, Hill MN, Winstanley CA.
    J Psychiatry Neurosci; 2017 Mar 01; 42(2):131-138. PubMed ID: 28245177
    [Abstract] [Full Text] [Related]

  • 19. Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450.
    Bansal S, Maharao N, Paine MF, Unadkat JD.
    Drug Metab Dispos; 2020 Oct 01; 48(10):1008-1017. PubMed ID: 32587099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.